1. Home
  2. HLI vs BIO Comparison

HLI vs BIO Comparison

Compare HLI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Houlihan Lokey Inc.

HLI

Houlihan Lokey Inc.

HOLD

Current Price

$184.42

Market Cap

14.4B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$325.65

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLI
BIO
Founded
1972
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
14.4B
8.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
HLI
BIO
Price
$184.42
$325.65
Analyst Decision
Hold
Strong Buy
Analyst Count
9
4
Target Price
$203.63
$358.50
AVG Volume (30 Days)
425.5K
154.0K
Earning Date
01-27-2026
02-12-2026
Dividend Yield
1.31%
N/A
EPS Growth
26.59
N/A
EPS
6.19
N/A
Revenue
$2,565,361,000.00
$2,557,500,000.00
Revenue This Year
$15.19
$1.62
Revenue Next Year
$13.05
$2.26
P/E Ratio
$29.51
N/A
Revenue Growth
21.00
N/A
52 Week Low
$137.99
$211.43
52 Week High
$211.78
$373.69

Technical Indicators

Market Signals
Indicator
HLI
BIO
Relative Strength Index (RSI) 62.86 65.53
Support Level $173.68 $300.26
Resistance Level $185.84 $305.62
Average True Range (ATR) 3.52 7.60
MACD 0.85 2.31
Stochastic Oscillator 88.32 92.18

Price Performance

Historical Comparison
HLI
BIO

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: